Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Salt Lake City. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Salt Lake City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is an open-label, multi-site study of apalutamide with carotuximab in patients who have progressed on androgen receptor signaling inhibitor (ARSI) therapy. This study will begin with a safety assessment in the first 10 subjects (part 1: Safety Lead-in). If the combination is deemed safe, the trial will proceed to the Phase II stage. The purpose of this study is to compare progression free survival (PFS) between patients receiving apalutamide and apalutamide + carotuximab using Response Eval
Sponsor: Edwin Posadas, MD
Check if you qualify for this prostate cancer clinical trial in Salt Lake City, UT
If you're searching for prostate cancer treatment options in Salt Lake City, UT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Salt Lake City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.